O Brien Greene & Co. Inc Cuts Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

O Brien Greene & Co. Inc reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 6.8% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 4,105 shares of the biotechnology company’s stock after selling 300 shares during the period. O Brien Greene & Co. Inc’s holdings in Axon Enterprise were worth $1,208,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. ICA Group Wealth Management LLC purchased a new position in Axon Enterprise in the 4th quarter valued at approximately $26,000. Blue Trust Inc. increased its stake in Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares in the last quarter. Trivant Custom Portfolio Group LLC purchased a new position in Axon Enterprise in the 1st quarter valued at approximately $31,000. First PREMIER Bank purchased a new position in Axon Enterprise during the first quarter worth $33,000. Finally, Rise Advisors LLC increased its position in Axon Enterprise by 49.0% during the first quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company’s stock worth $45,000 after buying an additional 47 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Craig Hallum raised their price target on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Robert W. Baird raised their price target on Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 10th. JMP Securities raised their price target on Axon Enterprise from $375.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Jefferies Financial Group assumed coverage on Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target for the company. Finally, Bank of America assumed coverage on Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $380.00 price target for the company. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $365.38.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Julie A. Cullivan sold 900 shares of the business’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $353.53, for a total transaction of $318,177.00. Following the transaction, the director now owns 3,653 shares in the company, valued at $1,291,445.09. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Axon Enterprise news, President Joshua Isner sold 25,811 shares of the business’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the transaction, the president now owns 228,166 shares in the company, valued at $82,103,253.44. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Julie A. Cullivan sold 900 shares of the business’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $353.53, for a total value of $318,177.00. Following the transaction, the director now owns 3,653 shares in the company, valued at approximately $1,291,445.09. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 317,981 shares of company stock worth $115,662,734. 6.10% of the stock is owned by insiders.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $382.57 on Wednesday. Axon Enterprise, Inc. has a twelve month low of $189.12 and a twelve month high of $386.54. The stock has a market capitalization of $28.87 billion, a P/E ratio of 111.86, a PEG ratio of 10.30 and a beta of 0.94. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. The business’s fifty day moving average price is $340.58 and its 200 day moving average price is $315.24.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The firm had revenue of $504.00 million for the quarter, compared to analysts’ expectations of $478.35 million. During the same quarter last year, the firm earned $0.80 earnings per share. The firm’s revenue for the quarter was up 34.5% compared to the same quarter last year. As a group, research analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.